DOCS
Doximity, Inc.
$19.94
+0.55
(+2.84%)
Mkt Cap
3.73B
Volume
2,819,374
52W Range
17.15-76.51
Sector
Healthcare
Beta
1.35
EPS (TTM)
1.04
P/E Ratio
19.17
Revenue (TTM)
644.86M
Rev Growth (5Y)
+25.5%
EPS Growth (5Y)
+54.3%
AlphaVal · Fair Value
$21.35
Fair Value · Mild
6.6% below fair value
AlphaQuality · Grade
A-
Stable Earnings Power
81.7 / 100 composite
Company Description
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 644.86M | 570.40M | 475.42M | 419.05M | 343.55M | 206.90M | 116.39M | 85.69M |
| Net Income | 196.05M | 223.19M | 147.58M | 112.82M | 154.78M | 50.21M | 29.74M | 7.83M |
| EPS | 1.05 | 1.19 | 0.78 | 0.58 | 0.81 | 0.12 | 0.06 | 0.00 |
| Free Cash Flow | 0 | 266.74M | 178.29M | 173.42M | 120.88M | 78.36M | 21.95M | 14.12M |
| FCF / Share | N/A | 1.43 | 0.94 | 0.90 | 0.74 | 0.44 | 0.12 | 0.08 |
| Operating CF | 326.46M | 273.26M | 184.10M | 179.60M | 126.58M | 82.97M | 26.20M | 15.31M |
| Total Assets | 1.12B | 1.26B | 1.08B | 1.14B | 991.36M | 251.72M | 138.92M | 86.56M |
| Total Debt | 10.19M | 12.40M | 14.55M | 15.64M | 1.09M | 1.25M | 2.28M | 0 |
| Cash & Equiv | 219.18M | 209.61M | 96.78M | 158.03M | 112.81M | 66.39M | 48.43M | 33.61M |
| Book Value | 950.84M | 1.08B | 901.40M | 966.12M | 878.59M | 66.74M | 1.14M | 48.50M |
| Return on Equity | 0.21 | 0.21 | 0.16 | 0.12 | 0.18 | 0.75 | 26.18 | 0.16 |
| Metric | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 145.37M | 185.05M | 168.53M | 145.91M | 138.29M | 168.60M | 136.83M | 126.68M | 118.06M | 135.28M | 113.61M | 108.47M |
| Net Income | 19.11M | 61.56M | 62.06M | 53.32M | 62.46M | 75.20M | 44.15M | 41.38M | 40.62M | 47.96M | 30.60M | 28.41M |
| EPS | 0.10 | 0.33 | 0.33 | 0.28 | 0.33 | 0.40 | 0.24 | 0.22 | 0.22 | 0.26 | 0.16 | 0.15 |
| Free Cash Flow | 0 | 62.86M | 91.58M | 60.13M | 96.98M | 63.42M | 66.80M | 39.54M | 62.31M | 48.73M | 11.62M | 55.64M |
| FCF / Share | N/A | 0.34 | 0.46 | 0.32 | 0.51 | 0.34 | 0.36 | 0.21 | 0.33 | 0.26 | 0.06 | 0.29 |
| Operating CF | 109.52M | 60.89M | 93.94M | 62.10M | 98.49M | 65.19M | 68.35M | 41.24M | 63.94M | 50.05M | 12.90M | 57.20M |
| Total Assets | 1.12B | 1.16B | 1.26B | 1.20B | 1.26B | 1.17B | 1.12B | 1.07B | 1.08B | 1.00B | 1.03B | 1.15B |
| Total Debt | 10.19M | 10.69M | 11.27M | 11.84M | 12.40M | 12.95M | 13.49M | 14.03M | 14.55M | 15.06M | 15.05M | 15.63M |
| Cash & Equiv | 219.18M | 64.84M | 169.25M | 137.26M | 209.61M | 165.27M | 184.25M | 111.44M | 96.78M | 123.09M | 108.40M | 306.73M |
| Book Value | 950.84M | 979.30M | 1.10B | 1.03B | 1.08B | 1.03B | 961.20M | 913.58M | 901.40M | 864.61M | 871.47M | 990.79M |
| Return on Equity | 0.02 | 0.06 | 0.06 | 0.05 | 0.06 | 0.07 | 0.05 | 0.05 | 0.05 | 0.06 | 0.04 | 0.03 |
DOCS News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS
Doximity to Present at the William Blair 46th Annual Growth Stock Conference
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
Dr Martens profits jump as turnaround gains grip
Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss.
7 Healthcare AI Stocks Under $50 With Huge Upside Potential
DOCS vs. HIMS: Which Stock Is the Better Value Option?
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
Doximity Earnings: Strong AI Signals, But Monetization Still Pending
Down 25.7% in 4 Weeks, Here's Why Doximity (DOCS) Looks Ripe for a Turnaround